Q: What is Xgeva used for?

Xgeva is used to treat: Giant cell tumor of bone Hypercalcemia of malignancy Prevention of skeletal-related events in bone metastases

Q: How does Xgeva work?

Targeting Bone-Removing Cells Xgeva contains the active ingredient denosumab, which is a type of medicine called a monoclonal antibody. It is designed to target and bind to a protein in the body known as RANK ligand . In a healthy body, bone is constantly being broken down and rebuilt. However, certain types of cancer can cause the body to produce too much RANK ligand. This protein signals specialized cells called osteoclasts to break down bone at an abnormally fast rate. How Xgeva Helps By binding to RANK ligand, Xgeva prevents it from activating the osteoclasts. This process helps in several ways: Strengthening Bone: It slows down the destruction of bone tissue, which helps prevent fractures and other bone problems caused by cancer that has spread to the bones. Controlling Tumor Growth: In cases of giant cell tumor of bone, it can help slow the growth of the tumor by targeting the cells that make up the mass. Lowering Calcium Levels: When bone is broken down too quickly, it releases calcium into the bloodstream. By stopping this breakdown, Xgeva helps lower dangerously high calcium levels caused by cancer.

Q: What are the active ingredients in Xgeva?

The active ingredient in Xgeva is denosumab .

Q: What are the side effects of Xgeva?

Common side effects of Xgeva may include: Fatigue Nausea Diarrhea and others. Always consult with a healthcare professional about potential side effects.

Q: What drug class is Xgeva?

Xgeva belongs to the RANKL inhibitor drug class.

Q: What is the dosage of Xgeva and how do I take it?

Administration Xgeva is given as a subcutaneous injection, which means it is injected into the fatty tissue just under the skin. Common injection sites include the upper arm, the upper thigh, or the abdomen. This medication is usually administered by a healthcare provider in a clinic or hospital setting. Dosing Schedule For most conditions, Xgeva is injected once every four weeks. In specific cases, such as treating giant cell tumor of bone or high calcium levels caused by cancer, a healthcare provider may schedule additional doses during the first month of treatment. Important Considerations Supplements: It is important to take calcium and vitamin D supplements while receiving Xgeva to help maintain healthy calcium levels in the blood, unless your doctor tells you otherwise. Missed Doses: If you miss an appointment for your injection, contact your healthcare provider right away to reschedule. The medication should be given as soon as possible, and subsequent doses will be adjusted based on the new date.

Q: Is Xgeva safe during pregnancy and breastfeeding?

Pregnancy Xgeva can cause harm to an unborn baby. Animal studies have shown that exposure to this medication during pregnancy may lead to an increased risk of fetal loss, stillbirth, and problems with bone and lymph node development. It is generally advised that this medication should not be used by pregnant women. If you are a person of childbearing potential, your healthcare provider may require a pregnancy test before you start treatment to ensure you are not pregnant. You should use effective contraception while receiving Xgeva and for at least 5 months after your final dose. If you become pregnant while taking this medication or within 5 months after your last dose, notify your healthcare provider immediately. Breastfeeding It is currently unknown whether Xgeva passes into human breast milk. Because of the potential for serious side effects in a nursing infant, healthcare providers typically recommend either stopping breastfeeding or stopping the medication. The decision depends on the importance of the treatment to the mother's health.

Q: What forms and strengths does Xgeva come in?

Available Forms Xgeva is supplied as a sterile, preservative-free solution for subcutaneous injection. It is typically provided in a single-dose vial. Strengths This medication is available in a specific concentration for injection. The solution is clear and may range in color from colorless to pale yellow. It is intended for administration by a healthcare provider and should not be self-administered.

Q: What is the FDA approval status of Xgeva?

FDA Approval History The U.S. Food and Drug Administration (FDA) first approved Xgeva in 2010. Its approved uses include the prevention of skeletal-related events in patients with multiple myeloma or bone metastases from solid tumors. It is also indicated for the treatment of giant cell tumor of bone in adults and skeletally mature adolescents, as well as hypercalcemia of malignancy that is refractory to bisphosphonates. Boxed Warning Xgeva includes a Boxed Warning for severe hypocalcemia in patients with advanced chronic kidney disease. Patients with severe renal impairment, especially those on dialysis, are at an increased risk of developing dangerously low blood calcium levels. Monitoring of calcium levels and supplementation with calcium and vitamin D are typically required during treatment. Biosimilar Status In March 2024, the FDA approved the first interchangeable biosimilars for Xgeva. These products are biological medications that have been shown to be highly similar to Xgeva with no clinically meaningful differences in safety or effectiveness.

Question 1

What is Xgeva?

Accepted Answer

Xgeva is a monoclonal antibody designed to interfere with the natural process of bone resorption. It works by binding to a specific protein called RANK ligand, which is essential for the formation and activity of cells that break down bone.

By targeting this pathway, the medication helps to preserve bone structure and reduce the rate at which bone is lost. This action helps to stabilize the skeletal system in various medical contexts where bone health is compromised.

Question 2

What is Xgeva used for?

Accepted Answer

Xgeva is used to treat:

Giant cell tumor of bone
Hypercalcemia of malignancy
Prevention of skeletal-related events in bone metastases

Question 3

How does Xgeva work?

Accepted Answer

Targeting Bone-Removing Cells

Xgeva contains the active ingredient denosumab, which is a type of medicine called a monoclonal antibody. It is designed to target and bind to a protein in the body known as RANK ligand.

In a healthy body, bone is constantly being broken down and rebuilt. However, certain types of cancer can cause the body to produce too much RANK ligand. This protein signals specialized cells called osteoclasts to break down bone at an abnormally fast rate.

How Xgeva Helps

By binding to RANK ligand, Xgeva prevents it from activating the osteoclasts. This process helps in several ways:

Strengthening Bone: It slows down the destruction of bone tissue, which helps prevent fractures and other bone problems caused by cancer that has spread to the bones.
Controlling Tumor Growth: In cases of giant cell tumor of bone, it can help slow the growth of the tumor by targeting the cells that make up the mass.
Lowering Calcium Levels: When bone is broken down too quickly, it releases calcium into the bloodstream. By stopping this breakdown, Xgeva helps lower dangerously high calcium levels caused by cancer.

Question 4

What are the active ingredients in Xgeva?

Accepted Answer

The active ingredient in Xgeva is denosumab.

Question 5

What are the side effects of Xgeva?

Accepted Answer

Common side effects of Xgeva may include:

Fatigue
Nausea
Diarrhea
and others.

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Xgeva?

Accepted Answer

Xgeva belongs to the RANKL inhibitor drug class.

Question 7

What is the dosage of Xgeva and how do I take it?

Accepted Answer

Administration

Xgeva is given as a subcutaneous injection, which means it is injected into the fatty tissue just under the skin. Common injection sites include the upper arm, the upper thigh, or the abdomen.

This medication is usually administered by a healthcare provider in a clinic or hospital setting.

Dosing Schedule

For most conditions, Xgeva is injected once every four weeks. In specific cases, such as treating giant cell tumor of bone or high calcium levels caused by cancer, a healthcare provider may schedule additional doses during the first month of treatment.

Important Considerations

Supplements: It is important to take calcium and vitamin D supplements while receiving Xgeva to help maintain healthy calcium levels in the blood, unless your doctor tells you otherwise.
Missed Doses: If you miss an appointment for your injection, contact your healthcare provider right away to reschedule. The medication should be given as soon as possible, and subsequent doses will be adjusted based on the new date.

Question 8

Is Xgeva safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Xgeva can cause harm to an unborn baby. Animal studies have shown that exposure to this medication during pregnancy may lead to an increased risk of fetal loss, stillbirth, and problems with bone and lymph node development. It is generally advised that this medication should not be used by pregnant women.

If you are a person of childbearing potential, your healthcare provider may require a pregnancy test before you start treatment to ensure you are not pregnant. You should use effective contraception while receiving Xgeva and for at least 5 months after your final dose.

If you become pregnant while taking this medication or within 5 months after your last dose, notify your healthcare provider immediately.

Breastfeeding

It is currently unknown whether Xgeva passes into human breast milk. Because of the potential for serious side effects in a nursing infant, healthcare providers typically recommend either stopping breastfeeding or stopping the medication. The decision depends on the importance of the treatment to the mother's health.

Question 9

What forms and strengths does Xgeva come in?

Accepted Answer

Available Forms

Xgeva is supplied as a sterile, preservative-free solution for subcutaneous injection. It is typically provided in a single-dose vial.

Strengths

This medication is available in a specific concentration for injection. The solution is clear and may range in color from colorless to pale yellow. It is intended for administration by a healthcare provider and should not be self-administered.

Question 10

What is the FDA approval status of Xgeva?

Accepted Answer

FDA Approval History

The U.S. Food and Drug Administration (FDA) first approved Xgeva in 2010. Its approved uses include the prevention of skeletal-related events in patients with multiple myeloma or bone metastases from solid tumors. It is also indicated for the treatment of giant cell tumor of bone in adults and skeletally mature adolescents, as well as hypercalcemia of malignancy that is refractory to bisphosphonates.

Boxed Warning

Xgeva includes a Boxed Warning for severe hypocalcemia in patients with advanced chronic kidney disease. Patients with severe renal impairment, especially those on dialysis, are at an increased risk of developing dangerously low blood calcium levels. Monitoring of calcium levels and supplementation with calcium and vitamin D are typically required during treatment.

Biosimilar Status

In March 2024, the FDA approved the first interchangeable biosimilars for Xgeva. These products are biological medications that have been shown to be highly similar to Xgeva with no clinically meaningful differences in safety or effectiveness.

Question 11

What should I know about Xgeva and cost?

Accepted Answer

Factors Influencing Cost

The total price you pay for Xgeva can be influenced by several variables:

Insurance Coverage: Most private insurance plans and Medicare Part B typically cover Xgeva, but your out-of-pocket costs like copays or coinsurance will depend on your specific plan.
Administration Fees: Because Xgeva is administered as a subcutaneous injection by a healthcare professional, you may be charged for the office visit and the procedure in addition to the medication itself.
Treatment Setting: Costs may differ depending on whether you receive the injection at a doctor's office, an outpatient clinic, or a hospital facility.

Biosimilar Options

The FDA has approved interchangeable biosimilars for Xgeva, such as Wyost. A biosimilar is a biological product that is highly similar to and has no clinically meaningful differences from an existing FDA-approved reference product. Interchangeable biosimilars may be substituted for the brand-name drug at the pharmacy level, depending on state laws, which can help lower treatment expenses.

Financial Assistance Programs

Patients who are uninsured or underinsured may have access to financial assistance. The manufacturer often provides support programs or copay cards to help eligible patients reduce their out-of-pocket costs. Additionally, some non-profit organizations offer grants to help cover the cost of specialized medications for bone health and cancer-related conditions.

Xgeva

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Xgeva

Hospitals.net Disclosure